Verastem (VSTM) Other Non Operating Income (2019 - 2026)
Verastem's (VSTM) quarterly Other Non Operating Income came in at -$61000.0 in Q1 2026, down 52.5% year-on-year from -$128421.1 in Q1 2025, and down 64.86% quarter-over-quarter from -$37000.0 in Q3 2025.
Verastem (VSTM) Other Non Operating Income (2019 - 2026) Analysis & Trends
Verastem's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$61000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 52.5% year-over-year to -$61000.0 in Q1 2026; TTM through Mar 2026 was -$208000.0, a 56.39% decrease from a year earlier, with the FY2025 full-year figure at -$1.8 million, down 1384.55% from the prior year.
- Other Non Operating Income retreated to -$61000.0 in Q1 2026 per VSTM's latest filing, from -$37000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $28000.0 in Q1 2022 and bottomed at -$110000.0 in Q2 2025.
- The 5-year median for Other Non Operating Income is -$27000.0 (2024), against an average of -$27062.5.
- Across the five-year window, Other Non Operating Income plunged 766.67% in 2023 and soared 116.33% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$7000.0 in 2022, then tumbled by 600.0% to -$49000.0 in 2023, then surged by 116.33% to $8000.0 in 2024, then slumped by 562.5% to -$37000.0 in 2025, then tumbled by 64.86% to -$61000.0 in 2026.
- Per Business Quant, the three latest VSTM Other Non Operating Income figures stand at -$61000.0 (Q1 2026), -$37000.0 (Q3 2025), and -$110000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -110,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -40,000.00 |
| Mar 31, 2023 | -7,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2020 | -1.58 Mn |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 600,000.00 |